Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trial.
BMC Neurol
; 17(1): 7, 2017 Jan 10.
Article
in En
| MEDLINE
| ID: mdl-28068987
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cerebellar Ataxia
/
Leucine
Type of study:
Clinical_trials
/
Guideline
/
Observational_studies
Limits:
Adult
/
Humans
Language:
En
Journal:
BMC Neurol
Journal subject:
NEUROLOGIA
Year:
2017
Type:
Article
Affiliation country:
Germany